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The amino acid sequence ofangiogenin solated from bovine milk was deduced by gas-phase quencing of the protein 
and its fragments. The protein contains 125 residues and has a calculated molecular mass of 14577 Da. The sequence 
is highly homologous (65% identity) to the sequence ofhuman angiogenin, most of the differences being the result of 
conservative r placements. Like human angiogenin, the bovine protein is also homologous tobovine pancreatic RNase 
A (34% identity) and the three major active site residues known to be involved in the catalytic process, His-14, Lys-41 
and His-115, are conserved. When tested against conventional substrates for RNase A activity, bovine angiogenin dis- 
plays the same selective ribonucleolytic a tivity as human angiogenin. The sequence ofbovine angiogenin contains the 
cell recognition tripeptide Arg-Gly-Asp which is not present in the human protein. 
Protein sequence; Ribonuclease; Angiogenesis; Angiogenin; (Bovine milk) 
1. INTRODUCTION 
Human angiogenin, isolated from HT-29 tumor 
condit ioned media [11 and from human plasma [2] 
by the group of Vallee is able to induce blood 
vessel growth in the chick chorioallantoic mem- 
brane and the rabbit cornea. 
The primary structure of this small single-chain 
protein (Mr = 14400) has significant homology 
(35O7o identity) with human pancreatic RNase A 
[3]. This homology was shown to be biologically 
funct ional  as human angiogenin displays specific 
r ibonucleolytic activities, catalyzing the cleavage 
of 28 and 18 S rRNA [4]. Both angiogenic and 
RNase activities are selectively inhibited by placen- 
ta r ibonuclease inhibitor [5]. 
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rue Calmette, 59109 Lille Cedex, France 
Abbreviations: RNase, ribonuclease; HPLC, high-pressure li- 
quid chromatography; CNBr, cyanogen bromide; A, C, G and 
U, adenylic, cytidylic, guanylic and uridylic acids, respectively 
Bovine angiogenin was recently isolated from 
bovine serum [6] and, in 10-fold larger quantities, 
from bovine milk [7]. We report in this paper the 
complete amino acid sequence of the bovine pro- 
tein and its comparison with human angiogenin 
and bovine RNase A. 
2. MATERIALS  AND METHODS 
2,1. Materials 
Angiogenin was purified from bovine milk as described [7]. 
2.2. Sequence determination 
For reduction and alkylation, 1 nmol angiogenin purified 
from bovine milk [7] was dissolved in 1-propanol and 0.5 M 
sodium bicarbonate (1: 1, v/v) reduced with 10/4 of a 5°7o solu- 
tion of tributylphosphine under N2 for 1 h at room temperature 
and then alkylated with 9/~g of iodoacetamide. After 2 h, the 
product was desalted by reversed-phase chromatography using 
an octadecylsilane column eluted by two-step gradient. 
The S-aminocarboxymethylated protein was dissolved in 
0.1 M ammonium acetate, pH 4, and digested with S. aureus V8 
protease at 37°C for 24 h at an enzyme/substrate ratio of 1:50 
(w/w). 
Cleavage at Asn-Gly bonds was performed by treatment with 
2 M hydroxylamine hydrochloride in 0.2 M potassium car- 
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bonate containing 6 mg guanidine hydrochloride per,ug of sam- 
ple for 18 h at 23°C. In both cases, the resulting peptides were 
separated by reversed-phase HPLC (Nucleosil RP C 18 column, 
0.1°7o trifluoroacetic acid/acetonitrile, 0-60070 gradient over 
120 min). 
A sample was also submitted to CNBr cleavage for 10 h on 
glass fiber and the resulting fragments were sequenced without 
separation. Peptides were sequenced on an Applied Biosystems 
470 A gas phase sequencer. PTH amino acid derivatives were 
identified by HPLC using an Applied Biosystems 120 A on-line 
PTH analyzer. 
2.3. Ribonucleolytic activity 
Determination of the ribonucleolytic activity of bovine milk 
angiogenin was carried out according to the procedures de- 
scribed in [4] the following substrates were used: 
polyribonucleotides [poly(A); poly(U); poly(G); poly(C)]; 
cytidine cyclic 2',3'-phosphate (C>p); 2' ,5 '-dinucleotides 
(ApN, CpN, GpN, UpN, where N is A, C, G or V) from Sigma, 
wheat germ RNA from Calbiochem and 18 and 28 S RNA 
isolated from calf liver from Pharmacia. 
3. RESULTS AND DISCUSSION 
3.1. Sequence determination 
The complete amino acid sequence of  bovine 
angiogenin is shown in fig. 1, together with the pep- 
tides used for the sequence determination. The 
primary structure is made devoid of  any glycosyla- 
t ion signal sequence (Asn-X-Ser/Thr)  and no 
evidence for posttranslational modif icat ion was 
observed from the sequencing data. At  the dif- 
ference with human angiogenin whose N-terminal 
amino acid was blocked [3], extensive N-terminal 
sequencing of  the intact protein al lowed the deter- 
minat ion of  47 residues. This sequence perfectly 
fits the amino acid sequence recently reported [6] 
for angiogenin isolated from bovine serum. 
The complete sequence was deduced primarily 
based on the complete set o f  8 peptides generated 
by S. aureus V8 protease digestion of  the S- 
carboxymethylated protein, which were isolated by 
reversed-phase HPLC.  Except for residues 96-99  
which were determined by sequencing fragment 
HA-2,  because peptide V8-4 could not been se- 
quenced further than Tyr 95, all the residues 
shown in fig.1 were identif ied at least twice in the 
sequenc o analysis. The V-8 peptides were aligned 
by sequencing overlapping peptides generated by 
hydroxylamine cleavage of  Asn-Gly bonds and 
CNBr cleavage. 
3.2. Characteristics of the sequence 
Bovine angiogenin contains 125 residues cor- 
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Fig. 1. Amino acid sequence of bovine angiogenin and peptides 
used for sequence determination. SEQ, degradation of the 
intact protein; V8, peptides from digestion with S. aureus V8 
protease; CNBr, cyanogen bromide peptides; HA, peptides 
generated by cleavage with hydroxylamine. Dashed lines denote 
tracts of sequences inferred from comparison with sequences of 
different peptides. 
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responding to a calculated molecular mass of 
14577 Da [3]. Comparison of the sequence of 
human and bovine angiogenin shows (fig.2) a high 
degree of homology, consistent with usual in- 
terspecies variations: 79 of the 123 residues (64% 
identity) of human angiogenin are conserved, 
while, in the other positions, most differences are 
the result from conservative r placements. No gap 
had to be used for optimal alignment. Contrary to 
human angiogenin, in which the amino-terminal 
residue is pyroglutamic acid, in bovine angiogenin 
an additional alanine residue is found in this posi- 
tion, thus avoiding cyclisation of the glutamine 
side chain, following the removal of the leader se- 
quence by the signal peptidase. In the C-terminal 
position, an additional histidine residue is respon- 
sible, with the N-terminal alanine residue, for the 
difference in size between the two proteins. In both 
angiogenins, the six cysteine residues involved in 
disulfide bridges are found in the same positions 
reflecting the highly conserved tertiary structure of 
these molecules. 
As shown previously, one of the most surprising 
features of the human angiogenin sequence was its 
homology with the sequence of human pancreatic 
RNase A [4]. Here we demonstrate (fig.2) that the 
sequence of bovine angiogenin shares a similar 
homology (34% identity) with the sequence of 
bovine RNase A [8]. Human and bovine pancreatic 
RNases differ, however, from human and bovine 
angiogenin by the presence of one disulfide bridge 
(Cys-65-Cys-72 RNase numbering) in addition to 
the six cysteine residues located at the same posi- 
tions as in the angiogenin molecule. However, as 
this bond could be selectively reduced in RNase A 
without any effect on ribonucleolytic activity [9], it 
may be concluded that its presence is not critical 
for the enzymatic activity. 
As shown in table 1, among the different 
residues known to be present in the active region of 
RNase, most are also found in both angiogenin se- 
quences with the notable exception of Gln-69 
which is deleted in the two proteins. Another in- 
teresting difference is Phe at position 116 of bovine 
angiogenin, since the Phe - , Leu substitution in 
position 120 of RNase was shown to induce a 
7-fold decrease in its enzymatic activity [10]. 
Three amino acid residues are known to be 
directly involved in the catalytic process of pan- 
creatic RNase A: His-12, His- l l9  and Lys-41. In- 
terestingly, most of the amino acids surrounding 
these residues are conserved in the two angiogenins 
while they differ largely from those found in the 
corresponding RNase: 11 identical residues among 
Bovine RNas¢ 











1 10 XXX 20 
A D Y R Y I H F L T Q H Y D A K P N E F N 
< N S IR  Y T H F L T Q H Y D A K P D R E S 
K E S R [ ~ ~ ~ ] Q  H[ '~ I . .~ J  S D S P S S $ $ N Q 
40 xxx 50 60 
R R IP  - e K D IR IN  T F ! H 0 N K N I K D 
O $ PL..P..~_ c K~_ I  i IN T F 1 H 0 N K R S I K ,A ! C E IN  
N Q G R IC  K IP  V IN  T F [ '~ . . _~E P L V V Q N vL . .~ JF  Q 
70 8o 9o 
Y R 0 
It 
C K Q 
Bovine Angiogentn (3 E 
Human Angiogmin R A 








II° L ,  i F ° TI'T L"*. Ps W N L R I S K S IS  F Q Q 
G N "C ¥ K ' ~ $  M H IL~D L T R Y A 
100 110 xxx 120 125 .D D S V O IC  E - N O - L P V H F D E F 1 T P R H 
OF  N A ICE . -  NO LP  V H [ ~ D Q  I F R R P 
K E H Ale  R IG  S P Y V IP  V H ,F D A V E D S 
Fig.2. Comparison of amino acid sequences of bovine pancreatic ribonuclease [8], bovine angiogenin, human angiogenin [3], and 
human pancreatic ribonuclease (Chamoux, M. et al., unpublished). The alignment is numbered according to the bovine angiogenin 
sequence. Gaps were introduced in four places to retain the highest homologies. Identities between bovine angiogenin and either of 
the other proteins are boxed, xxx, residues known to be involved in catalysis by bovine RNase. 
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Table 1 
Residues in the active site of RNase and corresponding amino acids in human and bovine angiogenin: RNase 
residues and proposed roles were compiled by Shapiro et al. [4] from several X-ray and neutron diffraction 
studies of bovine RNase A and RNase S with inhibitors 
RNase Proposed role(s) Human Bovine 
residue angiogenin angiogenin 
residue residue 
His-12 removes 2'OH proton; H bonds to phosphate His-13 His-13 
His-119 protonates 5' O His- 114 His-I 15 
Lys-41 stabilizes intermediate; H bonds to 2'OH Lys-40 Lys-41 
Gln-ll H bonds from side chain NH to phosphate Gin-12 Gln-13 
Val-43 Ile-42 Arg-43 
Ash-44 Ash-43 Ash-44 
Thr-45 H bonds from NH and OH to pyrimidine 02 and N3 Thr-44 Thr-45 
Gin-69 H bonds from side chain C = O to purine N or 06 deleted deleted 
Ash-71 H bonds from side chain C=O to purine N or 06 Asn-68 Asp-69 
Glu-111 H bonds from CO0- to purine N1 Glu-108 Glu-109 
Phe-120 H bonds from amide NH to phosphate Leu-115 Phe-116 
Asp-121 H bonds from CO0- to His-ll9 Im Asp-ll6 Asp-ll7 
Ser-123 H bonds from OH to uracil 04 Ser-ll8 Ser-119 
an 11 amino acid stretch (9-19) surrounding 
His-14 (bovine numbering),  14 identical residues 
among a 16 amino acid stretch (35-51) surround- 
ing Lys-41, and 10 identical residues among a 12 
amino acid stretch (106-119) surrounding His-115. 
As these strong local homologies probably 
reflect similar unusual  r ibonucleolytic activities as 
those found with human angiogenin [4], we have 
determined the catalytic properties of bovine 
angiogenin. When the protein isolated from bovine 
milk was tested against polyribonucleotides, 
dinucleotides and wheat germ RNA no 
ribonucleolytic activity could be detected. 
However, when the hydrolysates of 18 and 28 S 
RNA isolated from calf liver were analysed by 
agarose gel electrophoresis under denaturing con- 
ditions degradation products were detected in- 
dicating an endonucleolytic a tivity of angiogenin. 
These results are in full agreement with those 
reported by Bond et al. [6] for the protein isolated 
from bovine serum and conf irm that bovine 
angiogenin has the same enzymatic activities as 
human angiogenin, 
A major  difference between bovine angiogenin 
and the three other related proteins is the presence 
in posit ion 67 of an Arg-Gly-Asp sequence. This 
tripeptidic sequence represents a recognition site in 
f ibronectin and other adhesive proteins from Arg- 
Gly-Asp directed adhesion receptor localized in en- 
dothelial cells [11]. Our prel iminary results, which 
show that bovine angiogenin i duces the prolifera- 
t ion of bovine brain capillary endothelial cells at 
concentrations ranging from 10 to 100 ng, suggest 
that this tripeptide could be involved in the interac- 
t ion of bovine angiogenin with the endothelial cells 
(Chamoux, M. et aI., unpublished). 
Acknowledgements: This work was supported by grants from 
the Centre National de la Recherche Scientifique (Unit6 de 
Recherche Associ6e D-1000, Director: Professor A. Tartar; 
Unit6 Associ6e 217, Director: Professor J. Montreuil), by the 
Institut National de la Sant6 et de la Recherche M6dicale; by the 
Institut Pasteur de Lille and by the Universit6 des Sciences et 
Techniques de Lille Flandres-Artois. 
REFERENCES 
[1] Fett, J.W., Strydom, D.J., Lobb, R.R., Alderman, E.M. 
and Vallee, B.L. (1985) Biochemistry 24, 5480-5486. 
[2] Shapiro, R., Strydom, D.J., Olson, K.A. and Vallee, 
B.L. (1987) Biochemistry 26, 5141-5146. 
[3] Strydom, D.J., Fett, J.W., Lobb, R.R., Alderman, E.M., 
Bethune, J.L., Riordan, J.F. and Vallee, B.L. (1985) 
Biochemistry 24, 5486-5494. 
[4] Shapiro, R., Riordan, J.F. and Vallee, B.L. (1986) 
Biochemistry 25, 3527-3532. 
[5] Shapiro, R. and Vallee, B.L. (1987) Proc. Natl. Acad. 
Sci. USA 84, 2238-2241. 
[6] Bond, M.D. and Vallee, B.L. (1988) Biochemistry 27, 
6282-6287. 
44 
Volume 241, number 1,2 FEBS LETTERS December 1988 
[7] Spick, G., Damart, D., Chamoux, M., Maes, P., Tartar, 
A. and Montreuil, J. (1988) Biochem. J., submitted. 
[8] Smyth, D.G., Stein, W.H. and Moore, S. (1963) J. Biol. 
Chem. 237, 1845-1850. 
[9] Sperling, R., Burstein, Y. and Steinberg, I.Z. (1969) 
Biochemistry 8, 3810-3820. 
[10] Lin, M.C., Gutte, B., Caldi, D.G., Moore, S. and 
Merrifield, R.B. (1972) J. Biol. Chem. 247, 4768-4774. 
[11] Ruoslahtli, E. and Pierschbacker, M.F. (1986) Cell 44, 
517-539. 
[12] Beintema, J.J., Weitzes, P., Weickmann, J.L. and Glitz, 
D.G. (1984) Anal. Biochem. 136, 48-64. 
45 
